Health Care & Life Sciences » Pharmaceuticals | Chongqing Lummy Pharmaceutical Co. Ltd.

Chongqing Lummy Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Chongqing Lummy Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Golden Eagle Stable Growth Equity Fund
24,500,000
4.19%
-789,837
8.43%
12/31/2017
800,000
0.14%
800,000
7.52%
12/31/2017
295,400
0.05%
27,200
0.13%
12/31/2017
33,500
0.01%
0
0.02%
01/31/2018
32,700
0.01%
16,200
0.1%
12/31/2017
14,200
0%
0
0.02%
12/31/2017
11,900
0%
200
0.07%
12/31/2017
7,738
0%
-1,400
0.06%
12/31/2017
Chang Xin CSI Central SOEs 100 Index Fund
0
0%
-94,420
0%
12/31/2017
British Columbia Inv Management Corp.
0
0%
-5,689,444
0%
03/31/2017

About Chongqing Lummy Pharmaceutical Co.

View Profile
Address
15th Floor, Tower B
Chongqing Chongqing 401123
China
Employees -
Website http://www.cqlummy.com
Updated 07/08/2019
Chongqing Lummy Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical. Its products include tumor drugs, antibacterial drugs, antifungal drugs, antiviral agent, digestive system agents, immune system agents, blood system agents, cardiovascular system agents, nervous system agents, electrolyte and acid-base balance and nutritional, liver disease auxiliary drugs, endocrinology system drugs, Chinese patent drugs, base large infusion, American ginseng and active pharmaceutical ingredients. The company was founded on September 6, 1999 and is headquartered in Chongqing, China.